Wallard et al. [37] confirmed in their study the impact of MMP1, MMP2, MMP9, and TIMP1 as potential diagnostic and therapeutic targets and supported the impact of those MMPs and TIMP1 as clinical markers for bladder cancer. The gene discussed is MMP9; the disease is urinary bladder carcinoma.